Paper34014152
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.
Ma L and 3 others. Emerg Infect Dis, 2021. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis. Papers, record 34014152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34014152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bordetella pertussis | Major topic |
| Whooping Cough | Major topic |
| Bacterial Outer Membrane Proteins | |
| Child | |
| Humans | |
| Pertussis Vaccine | |
| Virulence Factors, Bordetella |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI116186 | NIAID NIH HHS | United States | R21AI116186 | PubMed and NIH | NIH RePORTER |
| R21 AI156293 | NIAID NIH HHS | United States | R21AI156293 | PubMed and NIH | NIH RePORTER |
| R56 AI149787 | NIAID NIH HHS | United States | R56AI149787 | PubMed and NIH | NIH RePORTER |
| R21 AI159347 | NIAID NIH HHS | United States | R21AI159347 | PubMed and NIH | NIH RePORTER |
| R21 AI140399 | NIAID NIH HHS | United States | R21AI140399 | PubMed and NIH | NIH RePORTER |
| R21 AI142678 | NIAID NIH HHS | United States | R21AI142678 | PubMed and NIH | NIH RePORTER |
| R21 DC018496 | NIDCD NIH HHS | United States | R21DC018496 | PubMed and NIH | NIH RePORTER |
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29559630 | Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor. | Emerg Microbes Infect | 2018 | https://conductscience.org/library/papers/29559630 | PubMed |
| 2 | 28322702 | Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan. | Emerg Infect Dis | 2017 | https://conductscience.org/library/papers/28322702 | PubMed |
| 3 | 26371178 | Waning and aging of cellular immunity to Bordetella pertussis. | Pathog Dis | 2015 | https://conductscience.org/library/papers/26371178 | PubMed |
| 4 | 26160743 | The Decline of Pertussis-Specific Antibodies After Tetanus, Diphtheria, and Acellular Pertussis Immunization in Late Pregnancy. | J Infect Dis | 2015 | https://conductscience.org/library/papers/26160743 | PubMed |
| 5 | 17610513 | Autotransporter proteins: novel targets at the bacterial cell surface. | FEMS Microbiol Lett | 2007 | https://conductscience.org/library/papers/17610513 | PubMed |
| 6 | 16542440 | Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. | BMC Infect Dis | 2006 | https://conductscience.org/library/papers/16542440 | PubMed |
| 7 | 8538705 | A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8538705 | PubMed |
| 8 | 14765356 | Serologic response and antibody-titer decay in adults with pertussis. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/14765356 | PubMed |
| 9 | 10720524 | Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10720524 | PubMed |
| 10 | 26432908 | Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. | Vaccine | 2015 | https://conductscience.org/library/papers/26432908 | PubMed |
| 11 | 9796042 | Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. | Vaccine | 1998 | https://conductscience.org/library/papers/9796042 | PubMed |
| 12 | 16549796 | Pertactin beta-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16549796 | PubMed |
| 13 | 24256623 | Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/24256623 | PubMed |
| 14 | 1988935 | Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1988935 | PubMed |
| 15 | 30782265 | Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. | Euro Surveill | 2019 | https://conductscience.org/library/papers/30782265 | PubMed |
| 16 | 22353673 | Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. | Vaccine | 2012 | https://conductscience.org/library/papers/22353673 | PubMed |
| 17 | 32983069 | Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32983069 | PubMed |
| 18 | 9778731 | The great escape: structure and function of the autotransporter proteins. | Trends Microbiol | 1998 | https://conductscience.org/library/papers/9778731 | PubMed |
| 19 | 26389958 | New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. | Vaccines (Basel) | 2015 | https://conductscience.org/library/papers/26389958 | PubMed |
| 20 | 25686752 | Complement evasion by Bordetella pertussis: implications for improving current vaccines. | J Mol Med (Berl) | 2015 | https://conductscience.org/library/papers/25686752 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797595 | Whole-Cell and Acellular Pertussis Vaccines: A Narrative Review of Biological, Clinical, Safety and Programmatic Evidence, with Implications for Poland. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797595 | PubMed |
| 42797554 | Allele-Skewed HLA-DR Immunopeptidomes of Bordetella pertussis. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797554 | PubMed |
| 42685088 | Breakthrough infections and incomplete vaccine efficacy drive pathogen immune escape. | PLoS One | 2026 | https://conductscience.org/library/papers/42685088 | PubMed |
| 42471584 | Global phylogenomics of Bordetella pertussis ST2 reveals regional heterogeneity in China and lineage-specific genome evolution. | BMC Genomics | 2026 | https://conductscience.org/library/papers/42471584 | PubMed |
| 42369467 | A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420. | medRxiv | 2026 | https://conductscience.org/library/papers/42369467 | PubMed |
| 42347613 | Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347613 | PubMed |
| 42188610 | The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42188610 | PubMed |
| 42042773 | Flow Cytometric Assessment of Pertactin- and Tetanus Toxoid-Specific B-Cell Kinetics After Tdap Booster Vaccination in Healthy Adults. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42042773 | PubMed |
| 42030347 | Mechanisms of natural and vaccine-induced immunity to Bordetella pertussis. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42030347 | PubMed |
| 41991729 | Novel endogenous protein-based strategies to inhibit clinically relevant bacterial AB-type toxins including pertussis toxin. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41991729 | PubMed |
| 41937898 | EEG and seizures of pertussis encephalopathy in infants. | Front Pediatr | 2026 | https://conductscience.org/library/papers/41937898 | PubMed |
| 41911381 | Limited protective immunity to respiratory syncytial virus and pertussis among adults and healthcare workers in South Korea: A seroepidemiologic study. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41911381 | PubMed |
| 41893800 | Routine DTP Vaccination Coverage and Herd Immunity Against Pertussis in 2024 Did Not Recover to Pre-COVID-19 Levels Globally and in WHO Regions. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893800 | PubMed |
| 41878584 | Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024. | BMJ Public Health | 2026 | https://conductscience.org/library/papers/41878584 | PubMed |
| 41807281 | Pathogenicity and vaccine protection of circulating pertactin- and filamentous hemagglutinin-deficient Bordetella pertussis strains. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/41807281 | PubMed |
| 41600951 | Revisiting Whooping Cough: Global Drivers and Implications of Pertussis Resurgence in the Acellular Vaccine Era. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41600951 | PubMed |
| 41503374 | Study on the resurgence of pertussis based on a stage-structured dynamic model. | Infect Dis Model | 2026 | https://conductscience.org/library/papers/41503374 | PubMed |
| 41438608 | Comparing frequentist and Bayesian methods to identify drivers of pathogen strain invasion: A temporal case study of pertussis in the United States. | Infect Dis Model | 2026 | https://conductscience.org/library/papers/41438608 | PubMed |
| 41432344 | Structural and functional specialization of Bordetella pertussis DsbA for pertussis toxin folding. | Protein Sci | 2026 | https://conductscience.org/library/papers/41432344 | PubMed |
| 41333159 | [Analysis of the Pertussis Status in Jeju Special Self-Governing Province in 2024]. | Jugan Geongang Gwa Jilbyeong | 2025 | https://conductscience.org/library/papers/41333159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34014152
GET https://conductscience.org/api/papers/v1/34014152/references?page=2